![](/img/cover-not-exists.png)
Successful Drug Discovery || The Discovery of Osimertinib (TAGRISSO™): An Irreversible Inhibitor of Activating and T790M Resistant Forms of the Epidermal Growth Factor Receptor Tyrosine Kinase for the Treatment of Non-Small Cell Lung Cancer
Fischer, János, Klein, Christian, Childers, Wayne E.Volume:
10.1002/97
Year:
2018
Language:
english
DOI:
10.1002/9783527808694.ch12
File:
PDF, 968 KB
english, 2018